by Mark Bächer | Jun 23, 2021 | Allgemein |
Social loneliness has been a concept for many since the pandemic. Hansruedi Völkle and Mark Bächer have written a technical article on the occasion of the Swiss Patient Forum 2021 of Eupati CH on topics such as the importance of communication in times of the pandemic,...
by Mark Bächer | Apr 26, 2021 | Allgemein |
PTC Therapeutics is a global biopharmaceutical company from the USA that focuses on innovative small molecules and gene therapies for rare genetic diseases such as Duchenne muscular dystrophy (DMD) or AADC deficiency. Children as patients are a special challenge for...
by Mark Bächer | Mar 3, 2021 | Allgemein |
The SNSF has launched a National Research Program on Covid-19 in summer 2020. The NRP 78 will support research projects that aim to provide new insights into the coronavirus (SARS-CoV2), the spread and impact of Covid-19 diseases, and epidemiological, immunological...
by Mark Bächer | Feb 22, 2021 | Allgemein |
Eupati Switzerland’s Swiss Patient Forum is starting its fourth round. On March 19, 2021, representatives of patient organizations will meet with stakeholders from the healthcare sector for an exchange on “Patients in a Pandemic”. The event will be...
by Mark Bächer | Feb 8, 2021 | Allgemein |
In a retirement and nursing center in Germany, 14 seniors recently contracted the British Corona variant despite being vaccinated twice. Such events raise the question of how well the Covid -19 vaccine actually protects and whether one can continue to infect others...
by Mark Bächer | Jan 31, 2021 | Allgemein |
Covid-19 has brought various changes in our everyday lives, and above all it has triggered a huge digitalization push. This has made location-independent collaboration far easier. In times of a lockdown, virtual meetings are therefore becoming increasingly important...
